AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $3.9M invested in Akari Therapeutics in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$79K
2
+$73K
3
+$66.2K
4
OFW
Omnia Family Wealth
Florida
+$66K
5
HF
HRT Financial
New York
+$42K

Top Sellers

1
-$382K
2
-$49K
3
-$3K
4
TC
Truvestments Capital
Florida
-$1.28K
5
Morgan Stanley
Morgan Stanley
New York
-$534
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.19M
2
$1.1M
3
$765K
4
$350K
5
$237K
6
$79K
7
$73K
8
$42K
9
$32K
10
$15K
11
$8K
12
$4K
13
–
14
–
15
–